Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

GAMCO Names Doug Jamieson to Board: https://mms.businesswire.com/media/20201019005535/en/831358/5/CBS+logo.jpg
GAMCO Names Doug Jamieson to Board


GAMCO Investors, Inc. ("GAMCO") (NYSE: GBL) a global leader in diversified financial services announced that it has appointed Douglas R. Jamieson to its Board of Directors.



Doug Jamieson has been

American Express Chief Financial Officer to Participate in KBW Fintech Payments Conferencehttp://upload.wikimedia.org/wikipedia/commons/3/30/American_Express_logo.svg: By CoolKid1993 at en.wikipedia. Later version(s) were uploaded by Tkgd2007 at en.wikipedia. [Public domain], from Wikimedia Commons
American Express Chief Financial Officer to Participate in KBW Fintech Payments Conference


American Express Company (NYSE: AXP) Vice Chairman and Chief Financial Officer Jeffrey C. Campbell will participate in the Keefe, Bruyette & Woods (KBW) Fintech Payments Conference in New York on

DGAP-News: Takeover offer by financial investors unsuccessful - Aareal Bank continues to drive its growth strategy forward : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23689/375px-Aareal_Bank_Logo.svg.png
DGAP-News: Takeover offer by financial investors unsuccessful - Aareal Bank continues to drive its growth strategy forward
DGAP-News: Takeover offer by financial investors unsuccessful - Aareal Bank continues to drive its growth strategy forward
ISG to Publish Study on Digital Banking Platform Providers: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
ISG to Publish Study on Digital Banking Platform Providers


Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched a research study examining providers of digital banking solutions at a time when

Blue Bird Announces Price Increases for Type C and D Bus Model Types: https://mms.businesswire.com/media/20210323005889/en/866918/5/Nuvve+%281%29+%28002%29.jpg
Blue Bird Announces Price Increases for Type C and D Bus Model Types


Blue Bird Corporation, the leader in electric and low-emission school buses, announced today that it will implement a price increase to offset rising material, freight and labor costs primarily

Kohl’s Board of Directors Provides Update on Review of Unsolicited Expressions of Interest: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24601/Kohl's.svg.png
Kohl’s Board of Directors Provides Update on Review of Unsolicited Expressions of Interest


Kohl’s Corporation (NYSE:KSS) (“Kohl’s” or the “Company”) today issued the following statement:



The Kohl's Board of Directors (the Board) has determined, following a review with its independent

Agilent Highlights Integrated Automation Solutions at SLAS 2022Pexels:
Agilent Highlights Integrated Automation Solutions at SLAS 2022


Agilent Technologies Inc. (NYSE: A) highlights innovative laboratory automation solutions at the SLAS2022 International Conference and Exhibition held February 5 through February 9, 2022, at the

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Termination of office by mutual agreement with Chairman of the Management Board Dr. Rolf Breidenbach : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23717/225px-HELLA_Logo_3D_Background_4C_300dpi.jpg
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Termination of office by mutual agreement with Chairman of the Management Board Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Termination of office by mutual agreement with Chairman of the Management Board Dr. Rolf Breidenbach
Ubiquiti Inc. Reports Second Quarter Fiscal 2022 Financial Results
Ubiquiti Inc. Reports Second Quarter Fiscal 2022 Financial Results


Ubiquiti Inc. (NYSE: UI) (“Ubiquiti” or the “Company”) today announced its financial results for the second quarter fiscal 2022, ended December 31, 2021.



Second Quarter Fiscal 2022 Financial

GrafTech Reports Unaudited Fourth Quarter and Full Year 2021 Results: https://mms.businesswire.com/media/20191107005161/en/655890/5/GrafTech%2520International%2520%28Color%29.jpg
GrafTech Reports Unaudited Fourth Quarter and Full Year 2021 Results


GrafTech International Ltd. (NYSE: EAF) (GrafTech or the Company) today announced financial results for the quarter and year ended December 31, 2021.



Fourth Quarter Highlights




  • Net income of

Eaton Reports Record Fourth Quarter 2021 Results, Guidance on 2022 Outlook: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24410/Eaton_Color_logo.png
Eaton Reports Record Fourth Quarter 2021 Results, Guidance on 2022 Outlook


Power management company Eaton Corporation plc (NYSE:ETN) today announced that earnings per share were $1.37 for the fourth quarter of 2021. Excluding charges of $0.23 per share related to

SÜSS MicroTec SE: Dr. Dietmar Meister to leave Supervisory Board: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24072/S%C3%BCss_Microtec_logo.svg.png
SÜSS MicroTec SE: Dr. Dietmar Meister to leave Supervisory Board
SÜSS MicroTec SE: Dr. Dietmar Meister to leave Supervisory Board
DGAP-Adhoc: Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-Adhoc: Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets
DGAP-Adhoc: Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA and free cash flow for full year 2021 significantly exceed previous outlook: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23723/Ks_logo.svg.png
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA and free cash flow for full year 2021 significantly exceed previous outlook
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA and free cash flow for full year 2021 significantly exceed previous outlook
RM plc:  Notification of Preliminary Results:
RM plc: Notification of Preliminary Results
RM plc: Notification of Preliminary Results
EQS-News: Nordea Bank Abp: Transaction in Own Shares: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24153/330px-Nordea_logo.svg.png
EQS-News: Nordea Bank Abp: Transaction in Own Shares
EQS-News: Nordea Bank Abp: Transaction in Own Shares
Cannae Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call
Cannae Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call


Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) today announced that the Company will release its fourth quarter and full year 2021 financial results after the market close on

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4): https://mms.businesswire.com/media/20191106005906/en/305625/5/puma_logo_JPEG.jpg
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 1, 2022, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement

Sharon Yeshaya to Speak at the Credit Suisse Financial Services Forum: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23904/Morgan_Stanley_logo.svg.png
Sharon Yeshaya to Speak at the Credit Suisse Financial Services Forum


Sharon Yeshaya, Executive Vice President and Chief Financial Officer of Morgan Stanley, will speak at the Credit Suisse Financial Services Forum which will be held in Key Biscayne, Florida on

UBS Declares Coupon Payments on 5 ETRACS Exchange Traded Notes: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23977/300px-UBS_Logo_SVG.svg.png
UBS Declares Coupon Payments on 5 ETRACS Exchange Traded Notes


UBS Investment Bank today announced coupon payments for 5 ETRACS Exchange Traded Notes (the “ETNs”), all traded on the NYSE Arca.


NYSE Ticker


ETN Name and Prospectus Supplement*


Coupon

American States Water Company Announces Regular Common Dividends: https://mms.businesswire.com/media/20191104005851/en/54588/5/American_States2.logo.jpeg
American States Water Company Announces Regular Common Dividends


On February 1, 2022, the Board of Directors of American States Water Company (NYSE:AWR) approved a quarterly dividend of $0.365 per share on the Common Shares of the company. This action marks the

Power Integrations Reports Fourth-Quarter and Full-Year Financial Results: https://mms.businesswire.com/media/20191127005086/en/440630/5/PI_Logo_Short_black_blue_RGB150.jpg
Power Integrations Reports Fourth-Quarter and Full-Year Financial Results


Power Integrations (Nasdaq: POWI) today announced financial results for the quarter and year ended December 31, 2021. Net revenues for the fourth quarter of 2021 were $172.7 million, down two

Bill.com Reports Second Quarter Fiscal 2022 Financial Results: https://mms.businesswire.com/media/20210506006167/en/1095511/5/Bill.com_logo_for_Business_Wire.jpg
Bill.com Reports Second Quarter Fiscal 2022 Financial Results


Bill.com (NYSE: BILL), a leading provider of cloud-based software that simplifies, digitizes, and automates complex back-office financial operations for small and midsize businesses (SMBs), today

Navidea Biopharmaceuticals Announces Settlement of Platinum Litigation; Receipt of Noncompliance Notice from NYSE American: https://mms.businesswire.com/media/20191107006076/en/389794/5/navidea_cmyk.jpg
Navidea Biopharmaceuticals Announces Settlement of Platinum Litigation; Receipt of Noncompliance Notice from NYSE American


Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today